The Department of Veterans Affairs, National Cancer Institute and the Defense Department have formed a consortium with the goal to tailor care for people with cancerÂ using data on genes and proteins associated with the patients’ tumors.
VA said TuesdayÂ theÂ Applied Proteogenomics Organizational Learning and Outcomes consortium aimsÂ to develop a system for cliniciansÂ toÂ routinely screen tumors for gene and protein information as well asÂ obtain insight from data to determine possible treatment options.
APOLLO, which is part of the national Cancer Moonshot program, willÂ initially focus on lung cancer that VA said affectsÂ approximatelyÂ 8,000 military veteransÂ each year.
âAPOLLO will create a pipeline to move genetic discoveries from the lab to VA clinics,” said Veterans Affairs Secretary Robert McDonald.
VAÂ noted the program centersÂ on the concept of proteogenomics, whichÂ hasÂ been demonstrated in the NCI’sÂ Clinical Proteomic Tumor Analysis Consortium as a potential approach to produce therapeutic interventions for patients through the integration of proteomic and genomic processes.